Clinical Trial Update: A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. [Phase 1]

View source ↗

Summary

Phase I trial of vistusertib (AZD2014) in combination with weekly paclitaxel in advanced cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AZD2014 (vistusertib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED